Delivery Order SPE2DB22D3501-SPE2DB24FUT31
Award Date 2/28/24
Potential Completion Date 2/29/24
Potential Value $5.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, to provide NURTEC ODT 75 MG TABLET 8S for a total ceiling value of $12,472.34. The contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,576.66 to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The contract, which has an ultimate completion date of March 21, 2024, is for the supply of the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. This order was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract valued at $7,259.23 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a specialty pharmaceutical product, with a period of performance through March 11, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $15,837.61 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a prescription pharmaceutical product, with a period of performance through March 18, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $10,747.18 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading pharmaceutical sourcing and distribution company. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a period of performance through March 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $32,203.18 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This contract is for the provision of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has an ultimate completion date of April 18, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $4,998.58, is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. This award is a child contract under Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a potential value of $78,029.88. The contract has a completion date of March 6, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $2,231.73 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of NURTEC ODT 75 MG TABLET 8S. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded to AmerisourceBergen Drug Corp as the sole prime contractor. The IDC serves as the primary vehicle for AmerisourceBergen to deliver pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $4,933.64 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a period of performance through April 12, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025....
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUT31Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NURTEC ODT 75 MG TABLET 8S pharmaceutical products. The contract has a potential value of $5,550.66 and a completion date of February 29, 2024. This award is part of Amerisourcebergen Drug Corp's broader indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.
Generated 5/29/24, 9:10 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 2/28/24 |